Myriad Genetics, Inc. (MYGN)
NASDAQ: MYGN · Real-Time Price · USD
3.180
-0.040 (-1.24%)
At close: Sep 1, 2026, 4:00 PM EDT
3.150
-0.030 (-0.94%)
After-hours: Sep 1, 2026, 7:59 PM EDT

Myriad Genetics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
115.2149.6102.4132.156.9257.4
Short-Term Investments
---8.85881.4
Cash & Short-Term Investments
115.2149.6102.4140.9114.9338.8
Cash Growth
54.84%46.09%-27.32%22.63%-66.09%124.82%
Accounts Receivable
109.5115.3121.2114.3101.691.3
Receivables
109.5115.3121.2114.3101.691.3
Inventory
30.630.627.52220.115.3
Prepaid Expenses
33.735.437.435.23639.4
Restricted Cash
-1.79.51.22-
Total Current Assets
289332.6298313.6274.6484.8
Property, Plant & Equipment
158.9163.4172.4180.6187.3125.3
Long-Term Investments
----54.859
Goodwill
47.151.6286.3287.4286.8239.2
Other Intangible Assets
139153.4262.4354.1386.8410.8
Other Long-Term Assets
4.95.68.510.88.41.6
Total Assets
638.9706.61,0281,1471,1991,321

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
30.43032.325.828.829.6
Accrued Expenses
64.771.386.575.770.282.7
Current Portion of Leases
7.36.912.816.214.113
Current Income Taxes Payable
6.85.75.14.64.84
Other Current Liabilities
21.519.927.433.619.375
Total Current Liabilities
130.7133.8164.1155.9137.2204.3
Long-Term Debt
120.7119.939.638.5--
Long-Term Leases
82.58387.997.4130.979.3
Long-Term Deferred Tax Liabilities
-----35.8
Other Long-Term Liabilities
1.11.934.971.544.833.5
Total Liabilities
335338.6326.5363.3312.9352.9

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
10.90.90.90.80.8
Additional Paid-In Capital
1,5021,4891,4581,4161,2601,226
Retained Earnings
-1,200-1,123-756.8-629.5-366.2-254.2
Comprehensive Income & Other
0.80.8-0.8-3.7-8.9-5.1
Total Common Equity
303.9368701.1783.2885.8967.8
Shareholders' Equity
303.9368701.1783.2885.8967.8
Total Liabilities & Equity
638.9706.61,0281,1471,1991,321

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
210.5209.8140.3152.114592.3
Net Cash (Debt)
-95.3-60.2-37.9-11.224.7305.5
Net Cash Growth
-----91.92%-
Net Cash Per Share
-1.02-0.65-0.42-0.140.313.92
Filing Date Shares Outstanding
95.6593.5191.3189.8781.2280.02
Total Common Shares Outstanding
95.693.591.389.981.280
Working Capital
158.3198.8133.9157.7137.4280.5
Book Value Per Share
3.183.947.688.7110.9112.10
Tangible Book Value
117.8163152.4141.7212.2317.8
Tangible Book Value Per Share
1.231.741.671.582.613.97
Machinery
122.4121.5148.5147.6124.7112.4
Leasehold Improvements
78.280.478.591.367.938
SEC Filings: 10-K · 10-Q